Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
Gavi Process Guidelines
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
COVAX documents
COVAX AMC
Russian
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
DHI
VIS
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
Audit
Spanish
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
IATI
Social media toolkit
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Documents (9879)

Showing 12 of 9879 View All
Showing 219 of 824 pages

04 2016 2020 Strategy pdf

Gavi

05 Replenishment 2020 pdf

Gavi

06 Finance pdf

Gavi

07 Malaria vaccine pilots WHO pdf

Malaria Vaccine Pilot Implementation and Long - term Supply
Lusitana
Vaccinated in Malawi on 23 April 2019
Abigail Blessing
Vaccinated in Ghana on 30 April 2019
Elian
Vaccinated in Kenya on 13 Sept 2019
Dr Kate O?Brien, Director, Immunization, Vaccines & Biologicals, WHO
Gavi Alliance Board Meeting, 4 -5 December 2019
2
Progress has stalled, new tools are needed
(millions)
Cases
Current prevention tools 1
?45% reduction in uncomplicated malaria
?50% population sleeping under an ITN
?14% reduction in uncomplicated malaria
?6.6% population at risk protected
?12 countries implemented with 53% of
eligible children treated
?74% reduction in uncomplicated malaria
Insecticide -treated mosquito nets ( ITNs )
Indoor residual spraying
Intermittent preventive treatment (IPT) 2
222
230
233
241
248 248
241
238
235
239 239
229
226
221
217
214 217 219
190
200
210
220
230
240
250
260
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Number of malaria cases worldwide
1 Coverage numbers for Africa in 2017; 2 Numbers shown for Seasonal Malaria Chemoprevention , previously referred to as IPTc . Source: World Health Organization . World Malaria Report , 2018; Cochrane Database Syst Rev . 2018; (11)CD000363; Cochrane Database Syst Rev . 2010; (4)CD006657; Cochrane Database Syst Rev . 2012; (2)CD003756; The Lancet 374.9700 (2009): 1533 -1542
Progress has stalled

10 Update on development of strategy for MICs pdf

www.gavi.org
UPDATE ON DEVELOPMENT
OF STRATEGY FOR MIDDLE -
INCOME COUNTRIES (MICs)
BOARD MEETING
Santiago Cornejo
4 -5 December 2019, Delhi, India
Reach every child
Outline of the Board decision
2
Resource allocation: No more than 3.0% of Gavi 5.0 planned expenditure
Former
Gavi -
eligible
countries
Never
Gavi -
eligible
countries
GNI per capita
? Many of these countries face similar
challenges as former Gavi -eligible countries.
? To explore options to engage with these
countries on the same set of modalities
? To also explore options to engage with these
countries.
? However based on needs, t he modalities of
engagement may be different
Board Meeting
4-5 December 2019
Post -transition support to former Gavi -eligible countries to be institutionalised
Approach focusing on:
Political advocacy, technical assistance, innovation, access to pricing, and catalytic
financial support to jumpstart vaccine introductions

11 Risk Management Update pdf

Gavi

Subscribe to our newsletter